Incretinomiméticos e inibidores da dipeptidil peptidase-4: terapias inovadoras para o tratamento do diabetes tipo 2

Autor: Jaime A. Davidson, Jorge Luiz Gross, Erika B. Parente

Publikováno v: Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Arquivos Brasileiros de Endocrinologia & Metabologia v.52 n.6 2008
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 52, Issue: 6, Pages: 1039-1049, Published: AUG 2008

The prevalence of diabetes and impaired glucose tolerance is predicted to dramatically increase over the next two decades. Clinical therapies for type 2 diabetes mellitus (T2DM) have traditionally included lifestyle modification, oral anti-diabetic a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0eeab3843f7cc604e1db9a2e6ced44
https://doi.org/10.1590/s0004-27302008000600016